{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:44:32Z","timestamp":1782920672255,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research funding from Kite Pharma & Roche; Consultation fees from Roche and Leica Biosystems"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41375-026-02990-7","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:57:51Z","timestamp":1781078271000},"page":"1364-1367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4182-9355","authenticated-orcid":false,"given":"Jamie E.","family":"Flerlage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-0868","authenticated-orcid":false,"given":"Monica","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzi","family":"Birz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9725-4060","authenticated-orcid":false,"given":"Daphne","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1927-3514","authenticated-orcid":false,"given":"Dennis A.","family":"Eichenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-1091","authenticated-orcid":false,"given":"Sylvia","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-0194","authenticated-orcid":false,"given":"Richard T.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-0301","authenticated-orcid":false,"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-1018","authenticated-orcid":false,"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2640-5255","authenticated-orcid":false,"given":"Michael S.","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"2990_CR1","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]. Blood. 1994;84:1361\u201392.","journal-title":"Blood"},{"key":"2990_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1023\/A:1008375931236","volume":"10","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The world health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Ann Oncol. 1999;10:1419\u201332.","journal-title":"Ann Oncol"},{"key":"2990_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJM199708143370703","volume":"337","author":"T Marafioti","year":"1997","unstructured":"Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Falini B, Delsol G, et al. Origin of nodular lymphocyte-predominant Hodgkin\u2019s disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med. 1997;337:453\u20138.","journal-title":"N Engl J Med"},{"key":"2990_CR4","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of mature Lymphoid Neoplasms: A report from the clinical advisory committee. Blood. 2022;140:1229\u201353.","journal-title":"Blood"},{"key":"2990_CR5","unstructured":"The WHO classification of tumours haematolymphoid tumours (volume 11) 5th edition. 5th ed. IARC, 2024."},{"key":"2990_CR6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB, de O, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid neoplasms. Leukemia. 2022;36:1720\u201348.","journal-title":"Leukemia"},{"key":"2990_CR7","doi-asserted-by":"crossref","unstructured":"Palese M, Advani RH, Biney-Amissah D, Birz S, Collins GP, Hoppe RT, et al. Global nLPHL One Working Group (GLOW) research roadmap for nodular lymphocyte-predominant Hodgkin lymphoma. Pediatr Blood Cancer. 2025;72:e31646.","DOI":"10.1002\/pbc.31646"},{"key":"2990_CR8","doi-asserted-by":"crossref","unstructured":"Major A, Palese M, Jones A, Goes M, Binkley MS, Flerlage JE, et al. Patient and care partner perspectives on treatment decision-making in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): a Global nLPHL One Working Group (GLOW) study. Leuk Lymphoma. 2025;66:1328\u201332.","DOI":"10.1080\/10428194.2025.2474080"},{"key":"2990_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-025-63339-9","volume":"16","author":"A Subramanian","year":"2025","unstructured":"Subramanian A, Su S, Flerlage J, Alig S, Younes S, Marks LJ, et al. Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma. Nat Commun. 2025;16:1\u201316.","journal-title":"Nat Commun"},{"key":"2990_CR10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/modpathol.2009.54","volume":"22","author":"SH Nam-Cha","year":"2009","unstructured":"Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, Piris MA. Lymphocyte-rich classical Hodgkin\u2019s lymphoma: distinctive tumor and microenvironment markers. Mod Pathol. 2009;22:1006\u201315.","journal-title":"Mod Pathol"},{"key":"2990_CR11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","volume":"27","author":"Z Fan","year":"2003","unstructured":"Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003;27:1346\u201356.","journal-title":"Am J Surg Pathol"},{"key":"2990_CR12","doi-asserted-by":"crossref","unstructured":"Wilczynski A, G\u00f6rg C, Timmesfeld N, Ramaswamy A, Neubauer A, Burchert A, et al. Value and Diagnostic Accuracy of Ultrasound-Guided Full Core Needle Biopsy in the Diagnosis of Lymphadenopathy: A Retrospective Evaluation of 793 Cases. J Ultrasound Med. 2020;39:559\u201367.","DOI":"10.1002\/jum.15134"},{"key":"2990_CR13","doi-asserted-by":"crossref","unstructured":"Syrykh C, Chaouat C, Poullot E, Amara N, Fataccioli V, Parrens M, et al. Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey. Blood. 2022;140:2573\u201383.","DOI":"10.1182\/blood.2022015520"},{"key":"2990_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/cncy.22286","volume":"128","author":"S Gupta","year":"2020","unstructured":"Gupta S, Long SR, Natkunam Y, Kong CS, Gupta NK, Gratzinger D. Role of FNA with core biopsy or cell block in patients with nodular lymphocyte-predominant Hodgkin lymphoma. Cancer Cytopathol. 2020;128:570\u20139.","journal-title":"Cancer Cytopathol"},{"key":"2990_CR15","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","volume":"120","author":"A Louissaint Jr","year":"2012","unstructured":"Louissaint A Jr, Ackerman AM, Dias-Santagata D, Ferry JA, Hochberg EP, et al. Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. Blood. 2012;120:2395\u2013404.","journal-title":"Blood"},{"key":"2990_CR16","doi-asserted-by":"crossref","unstructured":"Binkley MS, Flerlage JE, Savage KJ, Akhtar S, Steiner R, Zhang X-Y, et al. International prognostic score for nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol. 2024;42:2271\u201380.","DOI":"10.1200\/JCO.23.01655"},{"key":"2990_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16375-6","volume":"11","author":"L Thurner","year":"2020","unstructured":"Thurner L, Hartmann S, Fadle N, Regitz E, Kemele M, Kim Y-J, et al. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma. Nat Commun. 2020;11:2465.","journal-title":"Nat Commun"},{"key":"2990_CR18","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","volume":"122","author":"S Hartmann","year":"2013","unstructured":"Hartmann S, Eichenauer DA, Pl\u00fctschow A, Mottok A, Bob R, Koch K, et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood. 2013;122:4246\u201352.;quiz 4292.","journal-title":"Blood"},{"key":"2990_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/bjh.13540","volume":"171","author":"AG Shankar","year":"2015","unstructured":"Shankar AG, Kirkwood AA, Hall GW, Hayward J, O\u2019Hare P, Ramsay AD. Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma - A review of clinical outcome based on the histological variants. Br J Haematol. 2015;171:254\u201362.","journal-title":"Br J Haematol"},{"key":"2990_CR20","doi-asserted-by":"crossref","unstructured":"Eichenauer DA, Basaran A, B\u00fchnen I, Fuchs M, von Tresckow B, Rosenwald A, et al. Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Leukemia. 2025;39:1735\u201343.","DOI":"10.1038\/s41375-025-02641-3"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02990-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:50:28Z","timestamp":1782917428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02990-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2990"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-02990-7","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MSB: No COI to disclose. Suzi Birz: No COI to disclose. EC: No COI to disclose related to this topic. DdeJ: No COI to disclose. DAE: No COI to disclose. JEF: No COI to disclose. SH: No COI to disclose. RTH: No COI to disclose. ESJ: No COI to disclose. WM: No COI to disclose. YN: Research funding from Kite Pharma & Roche; Consultation fees from Roche and Leica Biosystems. MP: No COI to disclose. LQ-M: No COI to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}